MI
MyDx, Inc. Stock: price and insider trades · United States
MyDx, Inc.: what insiders have been doing
Only a handful of insider records exist for MyDx, Inc., the last one from 8 May 2018, too few to describe a trend. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Insider Decl.
6
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
1 ops. · all time
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2018FY ended December 2018 · cache
Income statement
Revenue239.7k
Gross profit122.4k51% margin
Net income-7.4M-3098.5% margin
Last declaration on 8 May 2018
Declarations6 total
- 1,750,000,000 sharesCommon StockSEC:0001213900-18-005682:0
- 210,894 shares@ US$0.5025.8% of flowCommon StockSEC:0001213900-17-000277:1
- 30,000,000 sharesCommon StockSEC:0001213900-17-000277:0
- 51 sharesPreferred Stock (Series A Super Voting)SEC:0001213900-17-000277:2
- 300,000 shares@ US$1.0074.2% of flowPreferred Stock (Series B Convertible)SEC:0001213900-17-000277:3
- 350,000 sharesCommon StockSEC:0001213900-15-004754:0
6 of 6 declarations
About MyDx, Inc.
MyDx, Inc. is a company listed on the XNAS market, specializing in the development of diagnostic technologies for health. It focuses on improving quality of life through innovative solutions.
